Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation [NA]
This clinical trial evaluated CD8 donor lymphocyte infusion for relapse or residual disease after allogeneic stem cell transplantation. The …
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
Phase 2 study evaluating imatinib mesylate in combination with interferon alfa for chronic myeloid leukemia was terminated; results were pos…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) [Phase 1, Phase 2]
Clinical trial update on a reduced-intensity preparative regimen followed by stem cell transplantation (FAB) in several hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS [Phase 1, Phase 2]
An allogeneic transplant regimen using Mylotarg with fludarabine and melphalan was studied for acute myeloid leukemia, chronic myeloid leuke…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial update of Zarnestra (tipifarnib) in combination with Gleevec (imatinib) for chronic-phase chronic myeloid leukemia. The trial …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia [Phase 2]
Phase 2 trial evaluating peripheral stem cell transplantation with filgrastim in patients with acute or chronic myeloid leukemia; the study …
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating decitabine with peripheral stem cell transplantation in patients relapsed after bone marrow transplantat…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant [Phase 1]
Phase 1 safety study of interleukin-7 in recipients of a hematopoietic stem cell transplant (peripheral blood) has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 study evaluating the combination of dasatinib and vorinostat in patients with accelerated or blast phase chronic myeloid leukemia or…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluating the combination of imatinib mesylate and cytarabine in patients with chronic myeloid leukemia was termin…
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 trial comparing imatinib mesylate and dasatinib in previously untreated chronic phase chronic myeloid leukemia, with results poste…
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial [Phase 2]
A Phase 2 trial investigates discontinuing dasatinib in patients with chronic myeloid leukemia in chronic phase who have maintained complete…
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial update evaluating cordycepin plus pentostatin in patients with refractory acute lymphoblastic leukemia or chronic myeloid leuk…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia [Phase 2]
Phase 2 clinical trial update on bone marrow transplantation for patients with multiple myeloma, chronic myeloid leukemia (chronic phase), o…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Safety Assessment of a Multipeptide-gene Vaccine in CML [Phase 1]
This Phase 1 clinical trial update reports safety assessment data for a multipeptide-gene vaccine in chronic myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Unrelated Double Umbilical Cord Blood Units Transplantation [Phase 2, Phase 3]
Update on a Phase 2/3 trial evaluating unrelated double umbilical cord blood transplantation for acute and chronic leukemias, sponsored by T…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia [Phase 1, Phase 2]
This clinical trial update summarizes results from a Phase 1/2 study evaluating arsenic trioxide in combination with imatinib mesylate for c…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating paclitaxel in patients with refractory or recurrent acute leukemia or chronic myelogenous leukemia has…
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies [Phase 1, Phase 2]
This clinical trial update reports safety and early efficacy data for unrelated cord blood transplantation in adults with hematologic malign…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation [NA]
This clinical trial update reports on a study evaluating CD8+ T cell depletion as prophylaxis against graft-versus-host disease after periph…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders. [Phase 1]
A pediatric pharmacokinetic study of Glivec/Gleevec (imatinib) in children aged 1 to less than 4 with chronic myeloid leukemia, Philadelphia…
-
CLINICAL_TRIALS trial_result · 2012-02-03Clinical Trial Update: Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) [Phase 3]
Phase 3 TOPS trial comparing 400 mg versus 800 mg imatinib in chronic-phase chronic myeloid leukemia was terminated; results were posted in …
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation [Phase 2]
A Phase 2 study evaluating sirolimus with tacrolimus for graft-versus-host disease prophylaxis after unrelated donor stem cell transplantati…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP [Phase 1, Phase 2]
This clinical trial update reports Phase 1/Phase 2 results for the combination of PTK 787 and imatinib (Gleevec) in patients with acute myel…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia [Phase 1]
This Phase 1 safety study of MultiStem in patients with acute myeloid leukemia, chronic myeloid leukemia, or myelodysplastic syndromes has c…